Cite
Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study
MLA
Sabine Dettmer, et al. “Qualitative and Quantitative Evaluation of Computed Tomography Changes in Adults with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor: A Retrospective Observational Study.” Frontiers in Pharmacology, vol. 14, Sept. 2023. EBSCOhost, https://doi.org/10.3389/fphar.2023.1245885.
APA
Sabine Dettmer, Oliver Weinheimer, Annette Sauer-Heilborn, Oliver Lammers, Mark O. Wielpütz, Jan Fuge, Tobias Welte, Frank Wacker, & Felix C. Ringshausen. (2023). Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1245885
Chicago
Sabine Dettmer, Oliver Weinheimer, Annette Sauer-Heilborn, Oliver Lammers, Mark O. Wielpütz, Jan Fuge, Tobias Welte, Frank Wacker, and Felix C. Ringshausen. 2023. “Qualitative and Quantitative Evaluation of Computed Tomography Changes in Adults with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor: A Retrospective Observational Study.” Frontiers in Pharmacology 14 (September). doi:10.3389/fphar.2023.1245885.